BIO ESSENCE CORP.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.9M | $323.9K | $551.5K | $621.6K | $888.0K | $958.7K |
| Cost of Revenue | $469.2K | $106.9K | $274.1K | $293.3K | $589.7K | $731.4K |
| Gross Profit | $1.4M | $217.1K | $277.4K | $328.3K | $298.3K | $227.3K |
| Gross Margin | 75.3% | 67.0% | 50.3% | 52.8% | 33.6% | 23.7% |
| Operating Expenses | ||||||
| Research & Development | — | — | — | — | — | — |
| SG&A Expense | $497.8K | $676.5K | $345.6K | $763.1K | $1.1M | $907.9K |
| Operating Income | $900.0K | $-459.4K | $-345.6K | $-511.1K | $-857.5K | $-832.6K |
| Operating Margin | 47.4% | -141.8% | -62.7% | -82.2% | -96.6% | -86.8% |
| Interest Expense | — | — | $17.3K | $14.1K | $38.6K | $41.9K |
| Pretax Income | $897.0K | $-1.6M | $-403.0K | $-525.4K | $-644.3K | $-592.5K |
| Income Tax Expense | $800 | $800 | $1.6K | $2.5K | $3.3K | $3.3K |
| Net Income | $896.2K | $-1.3M | $-971.9K | $-809.7K | $-647.6K | $-595.8K |
| Net Margin | 47.2% | -404.0% | -176.2% | -130.3% | -72.9% | -62.2% |
| EPS (Basic) | $0.02 | $-0.03 | $-0.03 | $-0.02 | $-0.02 | $-0.02 |
| EPS (Diluted) | $0.02 | $-0.03 | $-0.03 | $-0.02 | $-0.02 | $-0.02 |
| Shares Outstanding (Basic) | 38.0M | 38.0M | 34.0M | 33.0M | 33.0M | 33.0M |
| Shares Outstanding (Diluted) | 38.0M | 38.0M | 36.0M | 33.0M | 33.0M | 33.0M |
| Dividends Per Share | — | — | — | — | — | — |